NCT04023110 · Interventional trial
Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab
Overall registry status Completed
Phase 1
Conditions Breast Cancer, Cardiomyopathies, Cardiotoxicity, Heart Failure, Risk Factor, Cardiovascular, Toxicity Due to Chemotherapy
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory